Qingdao’s automated wharf loads one standard container per second

https://japan.visitbeijing.com.cn/article/4IIUyyUiwCY

Qingdao’s Port is currently one of the most automated and efficient automated wharves in the world. It began its climb to the pinnacle of global port technology in 2013. In 2017, the first phase of the fully automated container terminal began operation. At the end of 2023, the Qingdao Automated Terminal was put into operation. It has progressed to full automation. As a fully automated container terminal and a “hydrogen + 5G” smart green terminal, the terminal has improved work efficiency by 30% and reduced manpower by 80%. The average loading and unloading capacity has reached 36.2 containers per hour, and the highest efficiency has reached 60.2 containers per hour

more insights

R&D institutions

 Universities in Qingdao

Photo: Haier Global Creative Research Center in Qingdao

http://www.vlandbiochem.com/article-5545-10977.html

On March 14, 2024, Evonik Vland Biotech (Shandong) Co., Ltd. was put into operation in Qingdao, China. The joint venture of Evonik China Co., Ltd. and Shandong Vland Biotech Co., Ltd. aims to develop and expand gut health solutions products including probiotics for farm animals in China. Evonik holds the majority with a share of 55 %.

Head of Evonik’s life science division Nutrition & Care, the Animal Nutrition business line is Johann-Caspar Gammelin.

The joint venture is headquartered in Vland Biotech Innovation Park in Qingdao, China, and Vland’s production facilities in Binzhou, Shandong Province, China., will be utilized.

“Benefiting from the strong innovation capabilities, applied technology expertise and excellent reputation of the two parent companies, we will deliver innovative products and solutions to the market, and create more value for our customers,” says Dr. Wang Xu, general manager of Evonik Vland Biotech (Shandong) Co., Ltd.

http://english.qibebt.cas.cn/ne/ns/202310/t20231027_397294.html

On Oct. 27, 2024, Prof. Juergen Popp Speaks, director of the Leibniz Institute of Photonic Technology and chair for Physical Chemistry at Friedrich-Schiller University, gave a talk at QIBEBT Distinguished Expert Forum and Visits Single-Cell Center on “Translational Biophotonics – Raman spectroscopy and AI a game changer !?” Popp elucidated the innovative technologies and potential applications of Raman spectroscopy in biophotonics, particularly its extensive use in clinical diagnostics. He emphasized the potential of multimodal methods combining Raman spectroscopy with other spectroscopic/optical technologies and how Raman can address today’s medical challenges, such as early cancer diagnosis and personalized treatments.

The visit was part of the Sino-German Scientific Partnership Program funded by the National Natural Science Foundation of China.

Back to …